Research Article
Evaluation of the Quality of Life in Moroccan Patients Diagnosed with Hypoparathyroidism
Table 3
QoL of patients with chronic HPt.
| Variables | Number (%) (N = 143) | Total score SF-36 (mean ± SD) | value |
| Age >60 years | 109 (76.3%) | 38.08 ± 13.62 | <0.001 | Age ≤60 years | 34 (23.7%) | 49.67 ± 14.7 |
| Gender: male | 19 (13.8%) | 42.08 ± 13.7 | 0.76 | Gender: female | 124 (86.7%) | 43.23 ± 11.12 |
| Marital status: single | 24 (16.8%) | 45.12 ± 14.2 | 0.45 | Marital status: married | 119 (83.2%) | 43.34 ± 10.6 |
| Postsurgical etiology | 128 (89.5%) | 41.32 ± 5.72 | 0.004 | Nonsurgical etiology | 15 (10.5%) | 50.13 ± 7.12 |
| Dose of calcium/day ≥2 g/day | 109 (76.2%) | 49.1 ± 3.3 | 0.013 | Dose of calcium/day <2 g/day | 34 (23.8%) | 43.2 ± 8.6 |
| Dose of alfacalcidol/day ≥1.5 μg/day | 111 (77.6%) | 47.1 ± 3.15 | 0.012 | Dose of alfacalcidol/day <1.5 μg/day | 32 (22.4%) | 40.4 ± 6.72 |
| The duration of disease: ≤10 years | 85 (59.4%) | 46.2 ± 8.3 | 0.82 | The duration of disease: >10 years | 58 (40.6%) | 44.7 ± 7.9 |
| Normocalcemia: yes | 101 (70.6%) | 47.7 ± 9.72 | 0.69 | Normocalcemia: no | 42 (29.4%) | 46.5 ± 10.15 |
| Therapeutic compliance: yes | 99 (69.2%) | 49.6 ± 5.72 | <0.031 | Therapeutic compliance: no | 44 (30.8%) | 41.3 ± 4.15 |
|
|
HPt: hypoparathyroidism. Bold values represent significant p values.
|